We have created a White Paper describing how continuous aseptic freeze-drying can address the major pain points of pharmaceutical batch freeze-drying such as: time-consuming, inefficient, energy-consuming, and poorly controlled.

Download the White Paper describing the advantages associated with a RheaVita’s NextGen continuous and controlled lyophilization.

The top 20 global pharma players are working together with RheaVita to improve their freeze-drying processes

Are you looking to accelerate your process and formulation development tracks?

Having trouble with formulation development of your biopharmaceutical product which requires freeze-drying?

New company video available